 Connection
Laurie Gaspar to Survival Rate
This is a "connection" page, showing publications Laurie Gaspar has written about Survival Rate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.787 |
|
|
|
-
Gaspar LE, McNamara EJ, Gay EG, Putnam JB, Crawford J, Herbst RS, Bonner JA. Small-cell lung cancer: prognostic factors and changing treatment over 15 years. Clin Lung Cancer. 2012 Mar; 13(2):115-22.
Score: 0.075
-
Amin NP, Miften M, Kavanagh B, Raben D, Camidge DR, Thornton D, Rochford N, Gaspar LE. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer. J Thorac Oncol. 2011 Sep; 6(9):1553-62.
Score: 0.074
-
Suh JH, Videtic GM, Aref AM, Germano I, Goldsmith BJ, Imperato JP, Marcus KJ, McDermott MW, McDonald MW, Patchell RA, Robins HI, Rogers CL, Wolfson AH, Wippold FJ, Gaspar LE. ACR Appropriateness Criteria: single brain metastasis. Curr Probl Cancer. 2010 May-Jun; 34(3):162-74.
Score: 0.068
-
Gaspar LE. Patient demographics in HOG LUN 01-24 versus SWOG 9504: apples versus oranges? Clin Lung Cancer. 2007 Sep; 8(8):466-7.
Score: 0.056
-
Gaspar LE. Optimizing chemoradiation therapy approaches to unresectable stage III non--small cell lung cancer. Curr Opin Oncol. 2001 Mar; 13(2):110-5.
Score: 0.036
-
Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer. 2000 Mar 01; 88(5):988-95.
Score: 0.034
-
Gaspar LE. Esophageal brachytherapy: a phantom menace? Int J Radiat Oncol Biol Phys. 1999 Oct 01; 45(3):549-50.
Score: 0.033
-
Komaki R, Scott CB, Byhardt R, Emami B, Asbell SO, Russell AH, Roach M, Parliament MB, Gaspar LE. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1998 Sep 01; 42(2):263-7.
Score: 0.030
-
Nieder C, Gaspar LE, Ruysscher D, Guckenberger M, Mehta MP, Rusthoven CG, Sahgal A, Gkika E. Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations. Strahlenther Onkol. 2018 05; 194(5):365-374.
Score: 0.029
-
Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, Koshy M, Kavanagh BD, Gaspar LE, Rusthoven CG. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 04; 12(4):734-744.
Score: 0.027
-
Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):406-413.
Score: 0.026
-
Gaspar L. Radiosurgery for AVMs: evaluating the risks and benefits. J Neurosurg. 1995 Aug; 83(2):381-2.
Score: 0.024
-
Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun; 123(2):251-7.
Score: 0.024
-
Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar; 122(1):135-43.
Score: 0.023
-
Gan GN, Weickhardt AJ, Scheier B, Doebele RC, Gaspar LE, Kavanagh BD, Camidge DR. Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):892-8.
Score: 0.022
-
Gaspar LE, Mackenzie IR, Gilbert JJ, Kaufmann JC, Fisher BF, Macdonald DR, Cairncross JG. Primary cerebral fibrosarcomas. Clinicopathologic study and review of the literature. Cancer. 1993 Dec 01; 72(11):3277-81.
Score: 0.022
-
Gaspar LE, Fisher BJ, MacDonald DR, LeBer DV, Halperin EC, Schold SC, Cairncross JG. Malignant glioma--timing of response to radiation therapy. Int J Radiat Oncol Biol Phys. 1993 Apr 02; 25(5):877-9.
Score: 0.021
-
Weickhardt AJ, Scheier B, Burke JM, Gan G, Lu X, Bunn PA, Aisner DL, Gaspar LE, Kavanagh BD, Doebele RC, Camidge DR. Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1807-1814.
Score: 0.020
-
Gaspar LE, Dawson DJ, Tilley-Gulliford SA, Banerjee P. Medulloblastoma: long-term follow-up of patients treated with electron irradiation of the spinal field. Radiology. 1991 Sep; 180(3):867-70.
Score: 0.019
-
McHaffie DR, Chabot P, Dagnault A, Suh JH, Fortin MA, Chang E, Timmerman R, Souhami L, Grecula J, Nabid A, Schultz C, Werner-Wasik M, Gaspar LE, Brachman D, Mody T, Mehta MP. Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of = 6 brain metastases: a multi-institutional phase II trial. J Neurooncol. 2011 Nov; 105(2):301-8.
Score: 0.018
-
Le QT, Moon J, Redman M, Williamson SK, Lara PN, Goldberg Z, Gaspar LE, Crowley JJ, Moore DF, Gandara DR. Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222. J Clin Oncol. 2009 Jun 20; 27(18):3014-9.
Score: 0.016
-
Kelly K, Chansky K, Gaspar LE, Albain KS, Jett J, Ung YC, Lau DH, Crowley JJ, Gandara DR. Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin Oncol. 2008 May 20; 26(15):2450-6.
Score: 0.015
-
Gandara DR, Chansky K, Albain KS, Gaspar LE, Lara PN, Kelly K, Crowley J, Livingston R. Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). Clin Lung Cancer. 2006 Sep; 8(2):116-21.
Score: 0.013
-
Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004 May 22; 363(9422):1665-72.
Score: 0.011
-
Shaw EG, Gaspar LE, Gibbs FA, Lewin AA, Wharam MD, Larson D, Bloomer WD, Buckley JA, Loeffler JS, Malcolm AW, Mendenhall WM, Schneider JF, Schupak KD, Simpson JR, Gutin PH, Rogers L, Leibel S. Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun; 215 Suppl:1121-8.
Score: 0.009
-
Simpson JR, Mendenhall WM, Schupak KD, Larson D, Bloomer WD, Buckley JA, Gaspar LE, Gibbs FA, Lewin AA, Loeffler JS, Malcolm AW, Schneider JF, Shaw EG, Wharam MD, Gutin PH, Rogers L, Leibel S. Follow-up and retreatment of brain metastasis. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun; 215 Suppl:1129-35.
Score: 0.009
-
Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ. Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer. Lung Cancer. 1999 Sep; 25(3):175-82.
Score: 0.008
-
Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, Kalemkerian GP. Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program. Chest. 1999 May; 115(5):1232-6.
Score: 0.008
-
Halperin EC, Herndon J, Schold SC, Brown M, Vick N, Cairncross JG, Macdonald DR, Gaspar L, Fischer B, Dropcho E, Rosenfeld S, Morowitz R, Piepmeier J, Hait W, Byrne T, Salter M, Imperato J, Khandekar J, Paleologos N, Burger P, Bentel GC, Friedman A. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):793-802.
Score: 0.006
-
Fernandez PM, Zamorano L, Yakar D, Gaspar L, Warmelink C. Permanent iodine-125 implants in the up-front treatment of malignant gliomas. Neurosurgery. 1995 Mar; 36(3):467-73.
Score: 0.006
-
Poplin EA, Khanuja PS, Kraut MJ, Herskovic AM, Lattin PB, Cummings G, Gaspar LE, Kinzie JL, Steiger Z, Vaitkevicius VK. Chemoradiotherapy of esophageal carcinoma. Cancer. 1994 Aug 15; 74(4):1217-24.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|